Track topics on Twitter Track topics that are important to you
Phone: 45 8870 8400
Fax: 45 8870 8403
Vivek Ramaswamy’s Roivant Sciences, the umbrella company to 14 Vant companies, including Datavant, Enzyvant Sciences, Urovant Sciences and others, raised another $200 million in equity financing.
In this episode of PharmaTelevision News Review, Fintan Walton talks with Denis Geffroy, Vice President Business Development at Almac Sciences at Almac. Filmed at BioTrinity 2010 in Newbury, UK, they ...
Roivant Sciences GMBH's urology-focused subsidiary Urovant Sciences Ltd. netted $130.2mm in an initial public offering of 10mm shares at $14 apiece (the low end of its $14-16 range).
October 9, 2018 (Investorideas.com Newswire) CV Sciences, Inc. (CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), preeminent supplier and manufacturer of hemp-derived phytocannabinoids
LAS VEGAS, Aug. 22, 2018 (GLOBE NEWSWIRE) — CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”) announced today that it has fully repaid the pr...
Roivant Sciences GMBH's urology-focused subsidiary Urovant Sciences Ltd. filed for an initial public offering on Nasdaq.
ATLANTA, GA / ACCESSWIRE / November 26, 2018 / Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a leader in the commercialization and development of prescription ophthalmic pharmaceuticals, today a...
(Leopoldina) Institutional responsibility for the doctorate at universities must be strengthened. This is the recommendation offered in the statement 'Doctorate in Transition', now available in Englis...
The aim of this study is to investigate whether a mobile application is useful for improving knowledge about professional competencies in students enrolled in Health Sciences degrees.
C8 sciences program is a cognitive training program mainly developed for the students, and the effectiveness is well established. The aim of this trial is to assess clinical efficacy of th...
Comparative randomized, single dose, two-way crossover open-label study to determine the bioequivalence of Sofosbuvir from Heterosofir 400 mg F.C.T (Pharmed Healthcare Co., Egypt) versus S...
The purpose of this study is to evaluate that whether the AML (acute myeloid leukemia)-CAMS (Chinese Academy of Medical Sciences)-2016 regimen, includes risk-stratified therapy and the use...
Comparative randomized, single dose, three way three sequence two treatment partial replicate crossover open-label study to determine the bioequivalence of Sofosbuvir from Sofodelevier 400...
Fluxome Sciences A/S was founded in February, 2002 with the aim of exploiting its unique technology and know-how to develop innovative and cost-effective bioprocesses. Today, a variety of molecules, r...
DVS Sciences is a life sciences technology company that has developed and manufactures a novel technology for highly multiplexed analysis of single cells. DVS Sciences has an R&D ...
Origin Sciences is a medical technology company developing innovative devices and tests to aid the detection and diagnosis of gastrointestinal diseases. Origin Sciences is based i...
T.A. Sciences www.TASciences.com is the first company in the world to offer its clients the ability to fight aging through the emerging science of telomere biology. T.A. Sciences was founded by Noel T...
We have published hundreds of Fluxome Sciences A/S news stories on BioPortfolio along with dozens of Fluxome Sciences A/S Clinical Trials and PubMed Articles about Fluxome Sciences A/S for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Fluxome Sciences A/S Companies in our database. You can also find out about relevant Fluxome Sciences A/S Drugs and Medications on this site too.
Food is any substance consumed to provide nutritional support for the body. It is usually of plant or animal origin, and contains essential nutrients, such as carbohydrates, fats, proteins, vitamins, or minerals. The substance is ingested by an organism ...